INCOME TAXES (Tables)

3 Months Ended

Mar. 31, 2025

Income Tax Disclosure [Abstract]

Schedule of Components of Income Tax Expense (Benefit)

During the three months ended March 31, 2025 and 2024, the Company recorded $8.3 million and ($0.9) million, respectively, of income tax expense (benefit) attributable to its TRSs.

	For the Three Months Ended
	March 31, 2025		March 31, 2024
	(dollars in thousands)
Current Tax Expense (Benefit)
Federal	$	—	$	—
State and local	13		—
Total current income tax expense (benefit)	$	13	$	—
Deferred Tax Expense (Benefit)
Federal	$	7,222	$	(824)
State and local	1,032		(119)
Total deferred income tax expense (benefit)	$	8,254	$	(943)
Total income tax expense (benefit)	$	8,267	$	(943)

Schedule of Effective Income Tax Rate Reconciliation

The difference between the Company's reported income tax provision and the U.S. federal statutory rate of 21.0% and state income tax rates is as follows:        

	For the Three Months Ended
	March 31, 2025		March 31, 2024
Statutory federal income tax rate	21.0	%	21.0	%
Non-taxable REIT income	(14.6	%)	(24.5	%)
State and local taxes	3.0	%	3.0	%
VIE and Other	(3.5	%)	0.3	%
Change in valuation allowance	—	%	—	%
Total provision	5.9	%	(0.2	%)